Skip to main content
Log in

CT screening for lung cancer - cost effectiveness debated

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Castleberry AW, Smith D, Anderson C, Rotter AJ, Grannis Jr FW.Cost of a 5-year lung cancer survivor: symptomatic tumour identification vs proactive computed tomography screening. British Journal of Cancer 101: 882-896, No. 6, 15 Sep 2009

  2. Reich JM.Cost-effectiveness of computed tomography lung cancer screening. British Journal of Cancer 101: 879-880, No. 6, 15 Sep 2009

  3. Duffy SW.Cost of a 5-year lung cancer survivor. British Journal of Cancer 101: 881, No. 6, 15 Sep 2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

CT screening for lung cancer - cost effectiveness debated. Pharmacoecon. Outcomes News 591, 11 (2009). https://doi.org/10.2165/00151234-200905910-00024

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905910-00024

Keywords

Navigation